Bond & Devick Financial Network’s Pliant Therapeutics PLRX Stock Holding History

Bond & Devick Financial Network’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Hold	100,160	–	–	0.03%	207
2026 Q1	$126K	Hold	100,160	–	–	0.04%	188
2025 Q4	$122K	Hold	100,160	–	–	0.03%	183
2025 Q3	$148K	Hold	100,160	–	–	0.04%	186
2025 Q2	$116K	Hold	100,160	–	–	0.04%	174
2025 Q1	$135K	Hold	100,160	–	–	0.05%	161
2024 Q4	$1.12M	Hold	100,160	–	–	0.48%	38
2024 Q3	$1.12M	Hold	100,160	–	–	0.48%	38
2024 Q2	$1.08M	Hold	100,160	–	–	0.58%	31
2024 Q1	$1.49M	Hold	100,160	–	–	0.81%	21
2023 Q4	$1.81M	Hold	100,160	–	–	1.03%	17
2023 Q3	$1.74M	Hold	100,160	–	–	1.12%	17
2023 Q2	$1.81M	Hold	100,160	–	–	1.13%	15
2023 Q1	$2.66M	Sell	100,160 -10,000	-9%	-$285K	1.7%	13
2022 Q4	$2.13M	Hold	110,160	–	–	1.52%	14
2022 Q3	$2.3M	Sell	110,160 -10,000	-8%	-$191K	1.9%	13
2022 Q2	$962K	Hold	120,160	–	–	0.84%	29
2022 Q1	$842K	Hold	120,160	–	–	0.67%	37
2021 Q4	$1.62M	Hold	120,160	–	–	1.22%	17
2021 Q3	$2.03M	Hold	120,160	–	–	1.68%	14
2021 Q2	$3.5M	Buy	+120,160	New	+$3.74M	2.89%	9

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bond & Devick Financial Network's PLRX Position: Q2 2026 in Review

Bond & Devick Financial Network held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 100,160 shares worth $114K. The position accounts for 0.03% of the portfolio, ranked #207.

Bond & Devick Financial Network first reported a position in PLRX in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.5M in Q2 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Bond & Devick Financial Network held 100,160 shares of Pliant Therapeutics worth $114K as of Q2 2026.
Bond & Devick Financial Network left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up 0.03% of Bond & Devick Financial Network's portfolio in Q2 2026, its #207 holding.
Bond & Devick Financial Network first reported a position in Pliant Therapeutics in Q2 2021 and has held it in 21 quarters since.
Bond & Devick Financial Network's Pliant Therapeutics position peaked at $3.5M in Q2 2021.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Bond & Devick Financial Network's 13F filing for Q2 2026, filed 16 Jul 2026.